Detail akcie ICU Medical Inc online

Business Summary: ICU Medical, Inc. develops, manufactures, and sells medical products used in infusion therapy, vascular access, and vital care applications. Its product portfolio includes ambulatory, syringe, and large volume IV pumps and safety software; dedicated and non-dedicated IV sets, needle free IV connectors, peripheral IV catheters, and sterile IV solutions; closed system transfer devices and pharmacy compounding systems; as well as a range of respiratory, anesthesia, patient monitoring, and temperature management products. Its Infusion Therapy products include Clave needlefree products, Neutron, and Tego. Its oncology products include ChemoLock Closed System Transfer Devices (CSTD) and Deltec GRIPPER non-coring needles for portal access. Its vascular access products include Safe-T Wing venipuncture and blood collection devices; Port-A-Cath implantable port, and Portex arterial blood sampling syringes. Its Tracheostomy product include Portex BLUselect PVC tracheostomy tubes.
Financial Summary: BRIEF: For the six months ended 30 June 2024, ICU Medical Inc revenues increased 4% to $1.16B. Net loss increased from $19.7M to $60.9M. Revenues reflect Consumables segment increase of 7% to $505.9M, Vital Care segment increase of 2% to $336.3M, United States segment increase of 6% to $749.3M, EMEA segment increase of 2% to $193.7M. Higher net loss reflects Selling, general and administrative increase of 5% to $316.7M (expense).